Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00357266 · ClinicalTrials.gov registry record

Differences in Genes and Proteins in Active and Controlled Uveitis

A clinical trial, sponsored by National Eye Institute (NEI).

Completed
Registry status
60
Enrollment target

NCT00357266 is a clinical trial that has completed, run by National Eye Institute (NEI). The registered enrollment target is 60 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00357266 has completed, sponsored by National Eye Institute (NEI).

COMPLETED
Registry status
60 participants
Enrollment target

Study Summary

This study will examine blood cells and other tissue samples from people with uveitis (eye inflammation) to try to gain a better understanding of this condition. It will look at 1) the differences in cells when uveitis is active and when it is under control; 2) the genes that control the functions of these cells during different stages of the condition; and 3) the proteins the cells make at these different stages. Patients 6 years of age or older with an eye inflammation of at least 8 weeks' duration may be eligible for this study. They must currently be enrolled in another NEI protocol for evaluation or treatment of uveitis. Participants will provide blood and possibly eye tissue samples as follows: Blood samples: Blood samples will be drawn, probably from an arm vein, during periods when the inflammation is bad and when it is quiet. No more than 60 mL (about 4 tablespoons) will be drawn at any visit, and no more than eight samples will be collected in 1 year. Tissue samples: For patients who require eye surgery, a sample of tissue or fluid that is removed as a routine part of surgery may be provided to investigators in this study for research purposes. Samples will be collected during patients' visits scheduled as part of their other protocol. The samples will be labeled with a special code number to preserve the patient's identity.

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2002-02-01
Est. Completion 2007-10-24

Sponsor

National Eye Institute (NEI)

221 total trials

What the Registry Record Tells You About NCT00357266

The ClinicalTrials.gov registry entry for NCT00357266 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Eye Institute (NEI), which has 221 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00357266 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00357266 about?

NCT00357266 is a clinical study titled "Differences in Genes and Proteins in Active and Controlled Uveitis". This study will examine blood cells and other tissue samples from people with uveitis (eye inflammation) to try to gain a better understanding of this condition. It will look at 1) the differences in cells when uveitis is active and when it is under control; 2) the genes that control the functions o...

What is the current status of trial NCT00357266?

This trial is currently completed. The enrollment target is 60 participants. The study started on 2002-02-01. Estimated completion is 2007-10-24.

Who is sponsoring clinical trial NCT00357266?

This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.